Is Teva Pharmaceutical (TEVA) Trading at a Discount?
Sound Shore Management, an investment management firm, has released its investor letter for the fourth quarter of 2024. A ...
Teva share price struggles to recover following $6 billion market loss
The financial results were actually positive, at the higher end of analysts' forecasts, but profit guidance for 2025 ...
Seeking Alpha11d
TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel ...
BioPharma Dive1d
Sanofi, Teva add to case for new bowel disease drug
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be ...
Yahoo Finance15d
Axsome secures top drug’s future with Teva patent settlement
If Axsome doesn’t, Teva can enter the U.S. market with its copy on Sept. 30, 2038. Auvelity is one of three drugs Axsome sells and by far the company’s top product. Auvelity combines a form of ...
Investopedia7d
FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea
covering some of the most notable news stories of the time. SOPA Images / Contributor / Getty Images Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration ...
Nasdaq4d
Teva Pharmaceuticals and Alvotech Announce U.S. Launch of SELARSDI™ Biosimilar for Autoimmune Diseases
The U.S. Food and Drug Administration (FDA) has approved SELARSDI™ (ustekinumab-aekn), a biosimilar to Stelara® (ustekinumab), for treating various conditions including plaque psoriasis ...
SchaeffersResearch.com28d
Pharmaceutical Name Gearing Up for Earnings
The company will report earnings before the open on Jan. 29 Israel-based pharmaceutical giant Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is preparing for its latest quarterly earnings report ...